Green Planet Bio Engineering Co. Ltd. (GPLB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US3932241009
Price
0.03 USD
Market cap
580,185.66 USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
Green Planet Bio Engineering Co. Ltd. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -35,842.00 USD |
| Net income | -35,842.00 USD |
| Diluted EPS – continuing operations | 0.00 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Green Planet Bio Engineering Co. Ltd.
Green Planet Bioengineering Co., Ltd. does not have significant operations. It focuses on acquisition or merger with an existing business operation. Green Planet Bioengineering Co., Ltd. was founded in 2004 and is based in Aventura, Florida. Green Planet Bioengineering Co., Ltd. is a subsidiary of Global Fund Holdings Corp.
More stocks
- Exousia Bio, Inc. (LMMY)
- Triller Group Inc. (ILLR)
- Digital Brand Media & Marketing Group, Inc. (DBMM)
- IIOT-OXYS, Inc. (ITOX)
- NEUTRA CORP. (NTRR)
- Mitesco, Inc. (MITI)
- Greenlane Holdings, Inc. (GNLN)
- Leslie's, Inc. (LESL)
- Target Group Inc. (CBDY)
- GOOD GAMING, INC. (GMER)
- Mosaic ImmunoEngineering Inc. (CPMV)
- CANNABIS SUISSE CORP. (CSUI)
Not investment advice. All data without warranty, price as of 17.11.2026. Details in the risk notice.